[ Ссылка ]

This phase I trial of oral azacitidine plus R-CHOP seeks patients with previously untreated diffuse large B-cell lymphoma (DLBCL) or Grade 3B follicular lymphoma. The goal of the current study is to identify a dose and schedule of oral azacitidine that can be safely administered with R-CHOP. For more information call (212) 746-2919 or click on the link below: [ Ссылка ]



Lymphoma Cancer Treatment New York
Lymphoma Clinical Trials New York
Lymphoma Cancer Center New York
Lymphoma Symptoms NY
Lymphoma Cancer NY
CLL Treatment
Symptoms Of Lymphoma
Hodgkins Lymphoma
Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma Treatment
Lymphoma Treatment Options
Lymphoma Prognosis
What is Lymphoma
Alternative Lymphoma Cancer Treatment
Advanced Blood Cancer Treatment
Lymphoma Cancer Research

свернуть